Cargando…
Management of patients with allergic diseases in the era of COVID-19
In the early days of the coronavirus disease 2019 (COVID-19) pandemic, allergic diseases, especially asthma, were considered to be risk factors for severe COVID-19 infection, hospitalization, and death. These concerns stemmed from the idea that individuals with allergic diseases are generally more s...
Autor principal: | Lee, Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650355/ https://www.ncbi.nlm.nih.gov/pubmed/36229025 http://dx.doi.org/10.3345/cep.2022.00759 |
Ejemplares similares
-
Management of the patient with allergic and immunological disorders in the pandemic COVID-19 era
por: Patella, Vincenzo, et al.
Publicado: (2020) -
Management of Allergic Patients During the COVID-19 Pandemic in Asia
por: Lee, Jae-Hyun, et al.
Publicado: (2020) -
Clinical considerations and practical issues of allergic diseases in COVID-19 era
por: Jung, Sungsu
Publicado: (2022) -
Management of Allergic Fungal Rhinosinusitis Associated with Vision Loss During COVID-19 Era
por: Singh, Anup, et al.
Publicado: (2021) -
Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement
por: Scadding, Glenis K., et al.
Publicado: (2020)